Skip to content
TrialScanner

NCT02734004

A Phase I/II Study of MEDI4736 in Combination With Olaparib in Patients With Advanced Solid Tumors.

Phase 1/Phase 2Active, not recruitingAZNLeadIQVCollaborator

Registry record

Lead sponsor
AstraZeneca
Conditions
Ovarian; Breast; SCLC; Gastric Cancers
Primary completion
Sep 17, 2021Actual
Completion
Locked
Start
Locked
Enrollment
Locked
Interventions
Locked
Study type
Locked
Results on the registry
Locked
Record last updated
Locked

Open NCT02734004 on ClinicalTrials.gov

Enrollment, interventions, the start and completion dates and the change history are locked on 1 row here. Included with TrialScanner ($9.99 a month) and Signal8 Pro.

Unlock with TrialScanner

Recorded changes

0 changes recorded for this trial. The history, with each previous value, is part of TrialScanner.

Tracking since Nov 12, 2026. Changes before that date are not known to TrialScanner.

    NCT02734004: A Phase I/II Study of... | TrialScanner